Skip to main content

Table 1 Baseline Characteristics

From: CpG increases vaccine antigen-specific cell-mediated immunity when administered with hepatitis B vaccine in HIV infection

  Engerix-B
n = 19
Engerix B-CPG
N = 19
Male (n) 18 14
Prior Vaccine Failure (n) 10 9
Age (Mean ± SD) 42.9 ± 7.3 41.0 ± 7.4
CD4+ T cell count (Mean ± SD) 543 ± 228 647 ± 262
Proportion with HIV RNA <50 copies/mL 100% 100%